EFFECTIVENESS OF INCENTIVES ON STI TESTING UPTAKE: A TRIAL AMONG ABORIGINAL AND TORRES STRAIT ISLANDER YOUNG PEOPLE IN REMOTE CENTRAL AUSTRALIA (2015-2020).
Kate Whitford, Bronwyn Silver, Handan Wand, Stephen Bell, Skye McGregor, Basil Donovan, Christopher Fairley, Rebecca Guy, Nathan Ryder, John Boffa, James Ward, John Kaldor
{"title":"EFFECTIVENESS OF INCENTIVES ON STI TESTING UPTAKE: A TRIAL AMONG ABORIGINAL AND TORRES STRAIT ISLANDER YOUNG PEOPLE IN REMOTE CENTRAL AUSTRALIA (2015-2020).","authors":"Kate Whitford, Bronwyn Silver, Handan Wand, Stephen Bell, Skye McGregor, Basil Donovan, Christopher Fairley, Rebecca Guy, Nathan Ryder, John Boffa, James Ward, John Kaldor","doi":"10.1097/OLQ.0000000000002254","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Bacterial sexually transmissible infections (STIs) cause a substantial disease burden worldwide, and disproportionately impact young people. In Australia, Aboriginal and Torres Strait Islander people are a priority population in STI testing guidelines.</p><p><strong>Methods: </strong>The More Options for STI Testing (MOST) trial evaluated whether providing an incentive impacted STI testing rates in select central Australian communities. Aboriginal and Torres Strait Islander people aged 16 to 29 years were eligible for a A$30 phone voucher if they had an STI test at a participating Aboriginal community-controlled primary health care clinic. An interrupted time series analysis examined monthly STI test counts for chlamydia, gonorrhoea or syphilis from 2015 to 2020, to determine whether testing increased during the incentives phase (2018-2020).</p><p><strong>Results: </strong>There were a total of 10,457 visits to the clinic in which an STI test was conducted, 5,110 of which were during the incentives period. A total of 1,526 incentives were provided to eligible clients. The baseline and incentives periods were each divided into two phases to account for new clinic openings and the COVID-19 pandemic. Among men, average monthly visits for an STI test were 32.6 (baseline phase 1), 44.1 (baseline phase 2), 50.8 (incentives phase), and 35.4 (incentives/COVID-19 phase). Women had 93.5, 111.3, 118.8 and 113.4 visits respectively. No significant change in STI testing was observed during the incentives phase. The proportion of visits for an STI test where an incentive was paid (coverage) varied by month, from 36% to 76% of consultations.</p><p><strong>Conclusions: </strong>The limited impact of incentives could be explained by low coverage, or that the incentive was not motivating enough to overcome STI testing barriers. Future studies should investigate alternative methods of increasing STI testing in remote central Australia, including through primary care clinics.</p>","PeriodicalId":21837,"journal":{"name":"Sexually transmitted diseases","volume":" ","pages":""},"PeriodicalIF":1.7000,"publicationDate":"2025-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sexually transmitted diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/OLQ.0000000000002254","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Bacterial sexually transmissible infections (STIs) cause a substantial disease burden worldwide, and disproportionately impact young people. In Australia, Aboriginal and Torres Strait Islander people are a priority population in STI testing guidelines.
Methods: The More Options for STI Testing (MOST) trial evaluated whether providing an incentive impacted STI testing rates in select central Australian communities. Aboriginal and Torres Strait Islander people aged 16 to 29 years were eligible for a A$30 phone voucher if they had an STI test at a participating Aboriginal community-controlled primary health care clinic. An interrupted time series analysis examined monthly STI test counts for chlamydia, gonorrhoea or syphilis from 2015 to 2020, to determine whether testing increased during the incentives phase (2018-2020).
Results: There were a total of 10,457 visits to the clinic in which an STI test was conducted, 5,110 of which were during the incentives period. A total of 1,526 incentives were provided to eligible clients. The baseline and incentives periods were each divided into two phases to account for new clinic openings and the COVID-19 pandemic. Among men, average monthly visits for an STI test were 32.6 (baseline phase 1), 44.1 (baseline phase 2), 50.8 (incentives phase), and 35.4 (incentives/COVID-19 phase). Women had 93.5, 111.3, 118.8 and 113.4 visits respectively. No significant change in STI testing was observed during the incentives phase. The proportion of visits for an STI test where an incentive was paid (coverage) varied by month, from 36% to 76% of consultations.
Conclusions: The limited impact of incentives could be explained by low coverage, or that the incentive was not motivating enough to overcome STI testing barriers. Future studies should investigate alternative methods of increasing STI testing in remote central Australia, including through primary care clinics.
期刊介绍:
Sexually Transmitted Diseases, the official journal of the American Sexually Transmitted Diseases Association, publishes peer-reviewed, original articles on clinical, laboratory, immunologic, epidemiologic, behavioral, public health, and historical topics pertaining to sexually transmitted diseases and related fields. Reports from the CDC and NIH provide up-to-the-minute information. A highly respected editorial board is composed of prominent scientists who are leaders in this rapidly changing field. Included in each issue are studies and developments from around the world.